{"id": "1379452981834289153", "creation": 1617722194.0, "user_id": "1233901069366771712", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 1, "reply_count": 0, "like_count": 1, "quote_count": 0}}, "text": "Dynavax/Valneva Report Positive Results from Phase 1A COVID-19 Vaccine Trial\ud83d\udc89\n\nValneva plans to start a Phase 3 trial of their #COVID19 #vaccine with the $DVAX CpG 1018 adjuvant this month.\n\n$INRLF $ARCT $ATRA $VBIV $VXRT #stock #investing\n\nhttps://t.co/PT37LrpHdT", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#STOCK", "#INVESTING"]}